Healthcare sector faces surge in voice-phishing credential attacks
High-profile cybercrime groups are increasingly using voice-phishing to trick healthcare workers into handing over login credentials.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
Birch tar made by Neanderthal methods blocks wound bacteria
Recreated ancient birch tar inhibited Staphylococcus aureus, suggesting Neanderthals may have used the adhesive as an early wound treatment.
Scientists find hidden waste-clearance pathway in the back of the eye
A newly identified lymphatic route in the choroid, found in mice, challenges a century-old assumption and may offer new targets for glaucoma and macular degeneration.
Retinal Implant for Geographic Atrophy Shows Durable 3-Year Gains
A wireless retinal implant improved central vision in geographic atrophy patients for three years, though an expert flagged the number of deaths in the small trial.
Trump’s $90 Medicare Rebate Excludes Most Beneficiaries
A one-time $90 Part B premium rebate will reach only about a third of Medicare enrollees, drawing criticism as an election-year move.
Heart Transplant Candidacy: Don't Rely on PVR Alone, Study Suggests
A registry analysis found that high transpulmonary gradient, but not high pulmonary vascular resistance by itself, predicted worse survival after heart transplantation.
PDE9 Inhibitor Fails in Heart Failure; Lower Dose Shows Promise
Two phase II trials of tovinontrine missed their primary endpoint at the high dose, but post hoc data suggest a lower dose may still work.
Experts on Quack Medicines, Measles, and Unmet Needs
Expert commentary this week spans FDA enforcement, measles response, and new treatment frontiers.
High A1c Raises Risks After Cataract and Glaucoma Surgery
Two retrospective analyses presented at AAO found that higher preoperative hemoglobin A1c is associated with increased risk of cystoid macular edema after cataract surgery and infection after glaucoma tube-shunt surgery.
Ketamine's Off-Label Prescribing Lacks Safety Standards, Psychiatrists Warn
A new commentary argues that inconsistent oversight of off-label ketamine prescribing puts patients with addiction history at risk.
CMS Medicare Advantage Rule Is a Step, Not a Finish Line
The 2027 final rule improves payment integrity and quality measurement, but policymakers still need to modernize Medicare Advantage for younger, more diverse seniors.
China's Henlius, Amberstone Ink $440M T-Cell Engager Pact
Henlius Biotech has agreed to pay up to $440 million in milestones to collaborate with Amberstone Biosciences on T-cell engagers.
Acadia Misses Alzheimer’s Phase 2 Goal but Pushes On to Phase 3
Despite missing its primary endpoint, Acadia Pharmaceuticals and analysts see enough encouraging signals to justify advancing the Alzheimer’s program.
NIH Cuts and DoD Transfer Threaten Medical Research, Scientist Warns
A cancer survivor and NIH-funded researcher argues that proposed budget cuts and a transfer to the Defense Department would stall the pipeline of future cures.
Senator Young urges White House biotech czar to counter China
A US senator wants a senior biotech adviser in the White House to address competition from China's biopharma industry.
Roche and Atavistik Bio in $2B Deal for Allosteric Cardiometabolic Drugs
Roche will pay Atavistik Bio up to $2 billion, mostly tied to milestones, to discover allosteric small-molecule drugs for cardiometabolic diseases.
HHS deputy nominee Klomp clears Senate committee vote
Chris Klomp, a top RFK Jr. adviser, is one step closer to becoming HHS deputy secretary after a Senate panel vote.
Idaho Man Linked to 1982 Tylenol Murders
A man who died by suicide in Idaho decades ago may be connected to the unsolved cyanide poisonings that reshaped drug packaging safety.